Advanced Search

 

Study ID Status Title Patient Level Data
FMS10030 Completed A repeat dose study of inhaled budesonide, FP and MF to assess drug accumulation in adipose tissue Study Listed on ClinicalStudyDataRequest.com
FMS10032 Completed A study to compare PK of a single doe of fluticasone propionate in healthy male Japanse and Caucasian subjects Study Listed on ClinicalStudyDataRequest.com
FMS10033 Completed A randomised, single-blind, placebo-controlled study with 5-way cross-over design to investigate the systemic pharmacokinetics and pharmacodynamics of single inhaled doses (800mcg and 1600mcg) of Fluticasone Propionate and Mometasone Furoate in healthy subjects. Study Listed on ClinicalStudyDataRequest.com
FMS30058 Completed A multicenter, randomized, double-blind, parallel group, placebo-controlled, 12 week study of Fluticasone Propionate 44mcg BID and 88mcg BID delivered via CFC MDI and a valved holding chamber with facemask in subjects with asthma age 24 months to 47 months Study Listed on ClinicalStudyDataRequest.com
FMS30059 Completed A multicenter, randomized, double-blind, parallel group, placebo-controlled, 12 week study of Fluticasone Propionate 44mcg BID and 88mcg BID delivered via CFC MDI and a valved holding chamber with facemask in subjects with asthma age 6 months to 2 years Study Listed on ClinicalStudyDataRequest.com
FMS40001 Completed A randomised, double-blind, double-dummy, parallel group, multicentre study to compare the effect on growth measured by stadiometry of fluticasone propionate (100µg bd) administered via DISKUS™ with budesonide (200µg bd) administered via Turbuhaler in prepubescent children. Study Listed on ClinicalStudyDataRequest.com
FNM10003 Completed An open study to investigate the nasal bioavailability of intra-nasally administered fluticasone propionate administered as a solution formulation, HFA nasal MDI formulation and as the aqueous nasal spray during charcoal block in healthy subjects. Study Listed on ClinicalStudyDataRequest.com
FNM10004 Completed An open, three-period, balanced, incomplete block crossover study in healthy subjects to investigate the effect of 7 days co-administration of fluticasone propionate aqueous nasal spray (FPANS) with ritonavir, ketoconazole, or erythromycin on serum cortisol levels Study Listed on ClinicalStudyDataRequest.com
FNM30033 Completed A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy of a Four-week Course of Fluticasone Propionate Aqueous Nasal Spray (200mcg QD) on Ocular Systems Commonly Associated with Allergic Rhinitis Study Listed on ClinicalStudyDataRequest.com
FNM30034 Completed A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy of a Four-Week Course of Fluticasone Propionate Aqueous Nasal Spray (200mcg QD) on Ocular Symptoms Commonly Associated with Allergic Rhinitis Study Listed on ClinicalStudyDataRequest.com
FNM40017 Completed A Multi-Center, Randomized, Double-Blind, Parallel Gruop Study to Assess the Potential Growth Effects of a One-year Course of Fluticasone Propionate Aqueous Nasal Spray (200mcg QD) versus Placebo in Pre-pubescent, Pediatric Subjects with Perennial Allergic Rhinitis Study Listed on ClinicalStudyDataRequest.com
FNM40194 Completed A Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group, Two-Week Study Assessing the Efficacy of Fluticasone Propionate Aqueous Nasal Spray 200mcg every day Versus Montelukast 10mg every day in Subjects ≥15 Years Old with Seasonal Allergic Rhinitis (SAR) Study Listed on ClinicalStudyDataRequest.com
FNM40195 Completed A Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group, Two-Week Study Assessing the Efficacy of Fluticasone Propionate Aqueous Nasal Spray 200mcg every day Versus Montelukast 10mg every day in Subjects ≥15 Years Old with Seasonal Allergic Rhinitis (SAR) Study Listed on ClinicalStudyDataRequest.com
FNP40010 Completed A single centre, randomised, double blind, parallel group study to determine the efficacy and tolerability of Fluticasone propionate nasal drops (Nasules) 400mcg bd, 400mcg od and placebo nasal drops in adult patients with bilateral polyposis. Study Listed on ClinicalStudyDataRequest.com
FPD40009 Completed A Randomized, Double-Blind, Parallel Group Trial Assessing the Efficacy and Safety of Fluticasone Propionate Inhalation Powder (250mcg QD) and Placebo in Subjects at Least 12 Years of Age with Chronic Asthma Currently Receiving Short Acting Beta Agonist Alone Study Listed on ClinicalStudyDataRequest.com
FPD40010 Completed A Randomized, Double-Blind, Parallel Group Trial Assessing the Efficacy and Safety of Fluticasone Propionate Inhalation Powder (250mcg QD) and Placebo in Subjects at Least 12 Years of Age with Chronic Asthma Currently Treated with Inhaled Corticosteroids Study Listed on ClinicalStudyDataRequest.com
FPD40012 Completed A Randomized, Double-Blind, Double-Dummy, Parallel Group Comparison of Fluticasone Propionate Inhalation Powder (50mcg BID) with Oral Montelukast (5mg QD) in Children 6-12 Years of Age with Persistant Asthma Study Listed on ClinicalStudyDataRequest.com
FPD40013 Completed A Randomized, Double-Blind, Double-Dummy, Parallel Group Comparison of Fluticasone Proprionate Inhalation Powder (50mcg BID) with Oral Montelukast (5mg QD) in Children 6-12 with Persistant Asthma Study Listed on ClinicalStudyDataRequest.com
FPD40014 Completed A Randomized, Double-Blind 12-Week Comparative Trial of Fluticasone Propionate DISKUS 100mcg BID Versus Fluticasone Propionate DISKUS 100mcg BID And Oral Montelukast 10mg QD In Adults With Persistent Asthma. Study Listed on ClinicalStudyDataRequest.com
FPD40015 Completed A Randomized, Open-Label, Cross Over Trial, Assessing Ease of Use, Correctness of Use and Patient Preference of Fluticasone Propionate Inhalation Powder (100mcg BID) via the Diskus versus Fluticasone Propionate Aerosol via the Metered Dose Inhaler (88mcg BID) in Subjects at Least 12 Years of Age with Persistent Asthma Currently Receiving Short Acting Beta Agonists Alone Study Listed on ClinicalStudyDataRequest.com
FPD40016 Completed A Randomized, Open-Label, Cross Over Trial, Assessing Ease of use, Correctness of use and Patient Preference of Fluticasone Propionate Inhalation Powder (100mcg BID) via the DISKUS™ versus Fluticasone Propionate Aerosol via the Metered Dose Inhaler (88mcg BID) in Subjects at Least 12 Years of Age with Persistent Asthma Currently Receiving Short Acting Beta Agonists Alone. Study Listed on ClinicalStudyDataRequest.com
FPR10001 Completed A double blind, placebo controlled, single dose, crossover study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of inhaled reformulated FP (TIBAC) in comparison with the standard formulation FP. Study Listed on ClinicalStudyDataRequest.com
FPR10006 Completed A randomised, double blind, placebo controlled, cross over study to investigate the duration of action of inhaled doses of Fluticasone Propionate (1000mg) on airway responsiveness to adenosine-5'-monophosphate (AMP) in mild asthmatic patients Study Listed on ClinicalStudyDataRequest.com
FRX106365 Completed A randomized, controlled trial to evaluate the effects of nadroparin on survival and disease progression in patients with advanced malignancies of the lung, pancreas, or prostate Study Listed on ClinicalStudyDataRequest.com
GLP106073 Completed A single-blinded randomized, placebo-controlled, staggered-parallel, escalating-dose study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of subcutaneous injections of GSK 716155 in Subjects with type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.